Analytical Quality by Design-based development and validation of ultra pressure liquid chromatography/MS/MS method for glycopeptide antibiotics determination in human plasma
Authorized Users Only
2018
Authors
Stajić, Ana
Maksić, Jelena
Maksić, Đoko
Forsdahl, Guro
Medenica, Mirjana
Jančić-Stojanović, Biljana

Article (Published version)

Metadata
Show full item recordAbstract
Aim: An ultra pressure liquid chromatography (UPLC)/MS/MS method for vancomycin and teicoplanin determination in human plasma was developed in accordance with analytical quality by design (AQbD) concept and fully validated. Materials & methods: Chromatographic separation was performed on ACQUITY UPLC C-18 charge surface hybrid (CSH) column (2.1 mm x 50 mm, 1.7 mu m particle size) in gradient mode and the mobile phase consisted of 0.1% formic acid in water and pure acetonitrile. The experimental design methodology was used for the definition of optimal chromatographic and protein precipitation conditions. Results: The linearity ranges were 0.05-10 mu g ml(-1) for vancomycin and 0.5-200 mu g ml(-1) for total teicoplanin. The relative standard deviations for precision estimation were below 15% and the accuracy was within 85-115% for all quality control levels. Conclusion: The method was utilized for glycopeptide antibiotics bioanalysis.
Keywords:
AQbD / glycopeptide antibiotics / plasma / UPLC/MS/MSSource:
Bioanalysis, 2018, 10, 22, 1861-1876Publisher:
- Future Sci Ltd, London
Funding / projects:
- Modelling of different chromatographic systems with chemometrical approach in pharmaceutical analysis (RS-172052)
DOI: 10.4155/bio-2018-0181
ISSN: 1757-6180
PubMed: 30412677
WoS: 000452399800008
Scopus: 2-s2.0-85057740948
Collections
Institution/Community
PharmacyTY - JOUR AU - Stajić, Ana AU - Maksić, Jelena AU - Maksić, Đoko AU - Forsdahl, Guro AU - Medenica, Mirjana AU - Jančić-Stojanović, Biljana PY - 2018 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3080 AB - Aim: An ultra pressure liquid chromatography (UPLC)/MS/MS method for vancomycin and teicoplanin determination in human plasma was developed in accordance with analytical quality by design (AQbD) concept and fully validated. Materials & methods: Chromatographic separation was performed on ACQUITY UPLC C-18 charge surface hybrid (CSH) column (2.1 mm x 50 mm, 1.7 mu m particle size) in gradient mode and the mobile phase consisted of 0.1% formic acid in water and pure acetonitrile. The experimental design methodology was used for the definition of optimal chromatographic and protein precipitation conditions. Results: The linearity ranges were 0.05-10 mu g ml(-1) for vancomycin and 0.5-200 mu g ml(-1) for total teicoplanin. The relative standard deviations for precision estimation were below 15% and the accuracy was within 85-115% for all quality control levels. Conclusion: The method was utilized for glycopeptide antibiotics bioanalysis. PB - Future Sci Ltd, London T2 - Bioanalysis T1 - Analytical Quality by Design-based development and validation of ultra pressure liquid chromatography/MS/MS method for glycopeptide antibiotics determination in human plasma VL - 10 IS - 22 SP - 1861 EP - 1876 DO - 10.4155/bio-2018-0181 ER -
@article{ author = "Stajić, Ana and Maksić, Jelena and Maksić, Đoko and Forsdahl, Guro and Medenica, Mirjana and Jančić-Stojanović, Biljana", year = "2018", abstract = "Aim: An ultra pressure liquid chromatography (UPLC)/MS/MS method for vancomycin and teicoplanin determination in human plasma was developed in accordance with analytical quality by design (AQbD) concept and fully validated. Materials & methods: Chromatographic separation was performed on ACQUITY UPLC C-18 charge surface hybrid (CSH) column (2.1 mm x 50 mm, 1.7 mu m particle size) in gradient mode and the mobile phase consisted of 0.1% formic acid in water and pure acetonitrile. The experimental design methodology was used for the definition of optimal chromatographic and protein precipitation conditions. Results: The linearity ranges were 0.05-10 mu g ml(-1) for vancomycin and 0.5-200 mu g ml(-1) for total teicoplanin. The relative standard deviations for precision estimation were below 15% and the accuracy was within 85-115% for all quality control levels. Conclusion: The method was utilized for glycopeptide antibiotics bioanalysis.", publisher = "Future Sci Ltd, London", journal = "Bioanalysis", title = "Analytical Quality by Design-based development and validation of ultra pressure liquid chromatography/MS/MS method for glycopeptide antibiotics determination in human plasma", volume = "10", number = "22", pages = "1861-1876", doi = "10.4155/bio-2018-0181" }
Stajić, A., Maksić, J., Maksić, Đ., Forsdahl, G., Medenica, M.,& Jančić-Stojanović, B.. (2018). Analytical Quality by Design-based development and validation of ultra pressure liquid chromatography/MS/MS method for glycopeptide antibiotics determination in human plasma. in Bioanalysis Future Sci Ltd, London., 10(22), 1861-1876. https://doi.org/10.4155/bio-2018-0181
Stajić A, Maksić J, Maksić Đ, Forsdahl G, Medenica M, Jančić-Stojanović B. Analytical Quality by Design-based development and validation of ultra pressure liquid chromatography/MS/MS method for glycopeptide antibiotics determination in human plasma. in Bioanalysis. 2018;10(22):1861-1876. doi:10.4155/bio-2018-0181 .
Stajić, Ana, Maksić, Jelena, Maksić, Đoko, Forsdahl, Guro, Medenica, Mirjana, Jančić-Stojanović, Biljana, "Analytical Quality by Design-based development and validation of ultra pressure liquid chromatography/MS/MS method for glycopeptide antibiotics determination in human plasma" in Bioanalysis, 10, no. 22 (2018):1861-1876, https://doi.org/10.4155/bio-2018-0181 . .